Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
Bryan Johnson, 47, is contemplating shutting down or selling his anti-ageing startup, Blueprint.
The biotech entrepreneur recently launched a religion called "Don’t Die."
He says commercial activity is undermining his philosophical credibility.
Blueprint has faced financial pressures but Johnson denies any crisis.
Biotech entrepreneur and longevity enthusiast Bryan Johnson has revealed he is considering shutting down or selling his anti-ageing company, Blueprint. Speaking to Wired, the 47-year-old said his priorities have shifted towards developing his newly founded religion, "Don’t Die", which he believes better aligns with his philosophical ambitions.
“I am so close to either shutting it down or selling it,” Johnson said in the interview published Monday. “I don’t need the money, and it’s a pain-in-the-ass company.”
From business to belief
Johnson is widely known for Project Blueprint, his intense and expensive self-experimentation regimen aimed at reversing ageing. Launched in 2021, the programme reportedly costs him around $2 million annually and has included controversial practices such as blood transfusions from his son, which he later discontinued due to lack of observable benefits.
Blueprint, his startup, sells wellness products ranging from a £42 mushroom-based coffee alternative called “Super Shrooms” to a £44 “longevity mix” drink.
In March, Johnson publicly declared the founding of his own religion, “Don’t Die”, which evolved from the tagline of his wellness brand and Netflix documentary. “It seemed obvious that they’d say Don’t Die is how humanity saved itself and merged with AI,” he wrote on X.
However, he now believes that commercial interests may be at odds with his philosophical mission. “People see the business and give me less credibility on the philosophy side. I will not make that trade-off,” he told Wired.
Financial pressures and public perception
Earlier this year, The New York Times reported that Blueprint was missing its monthly break-even target by over £780,000 ($1 million), citing internal documents and former employees. Johnson responded to some of the allegations, but notably avoided directly addressing the financial data.
To Wired, he maintained that the company is not in a financial crisis. “We are break-even, and I’ve said that publicly many times. We’ve had profitable months, we’ve had loss months,” he said.
Blueprint originally emerged from requests by friends who were curious about the supplements Johnson was taking. “I was trying to do people a solid,” he said. Yet, the enterprise has grown into something that, he now feels, undermines the authenticity of his philosophical pursuits.
Survey of more than 12,000 UK women finds heavier, longer periods linked to long Covid
Symptom severity rises and falls across the menstrual cycle, worsening during periods
Tests reveal inflammation in womb lining and hormonal changes, but no damage to ovaries
Iron deficiency risk may exacerbate fatigue, dizziness and other common long Covid symptoms
Study highlights link between long Covid and menstrual changes
Women with long Covid are more likely to experience longer and heavier periods, putting them at increased risk of iron deficiency, researchers have found. The findings come from a UK survey of more than 12,000 women, which also showed that the severity of long Covid symptoms fluctuated across the menstrual cycle and often worsened during menstruation.
Findings from UK survey
Between March and May 2021, 12,187 women completed an online survey. Of these, more than 1,000 had long Covid, over 1,700 had recovered from the virus, and 9,400 had never tested positive. The study revealed that women with long Covid reported heavier and longer periods, as well as more frequent bleeding between cycles, compared with other groups.
A follow-up survey with 54 women showed that symptoms worsened in the two days before and during menstruation, pointing to a strong link between hormonal changes and long Covid severity.
Biological markers and test results
Researchers also analysed blood samples from 10 women with long Covid. These tests showed excessive inflammation in the womb lining and elevated levels of the hormone dihydrotestosterone, both of which may drive heavier menstrual bleeding. Importantly, there was no evidence that long Covid damaged ovary function.
Risks of iron deficiency
Heavier periods increase the risk of iron deficiency, which is already common among women of child-bearing age. Symptoms of iron deficiency — such as fatigue, shortness of breath and dizziness — overlap with common long Covid complaints, leaving women particularly vulnerable.
Dr Jacqueline Maybin of the University of Edinburgh, who led the work, said the findings could pave the way for more tailored treatments for women. “Our hope is that this will allow us to develop really specific treatments for women with long Covid who are suffering with menstrual disturbance. It may also lead to female-specific treatments for long Covid itself.”
Global and national impact of long Covid
An estimated 400 million people worldwide are living with or recovering from long Covid. In England alone, nearly 2 million people self-report as having symptoms lasting more than four weeks after infection. More than 200 symptoms have been recorded, with the most common including fatigue, brain fog, breathing difficulties, digestive problems, headaches and changes to smell and taste.
Expert views on treatment potential
Dr Viki Male, a reproductive immunology specialist at Imperial College London, said the findings support a biological explanation for the link. “Inflammation in the uterus is associated with heavy menstrual bleeding, so this could be the link between long Covid and prolonged or heavy periods,” she explained. She added that anti-inflammatory drugs already used to treat heavy periods may also be effective for women experiencing this symptom as part of long Covid.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Researchers from the UK and US analysed data from American households between 2004 and 2019
Hotter days linked to greater intake of sugary drinks and frozen desserts
Lower-income households most affected, research finds
Climate change could worsen health risks linked to sugar consumption
Study based on 15 years of US household food purchasing data
Sugary consumption rising with heat
People are more likely to consume sugary drinks and ice cream on warmer days, particularly in lower-income households, according to new research. The study warns that climate change could intensify this trend, adding to health risks as global temperatures continue to rise.
Sugar consumption is a major contributor to obesity, diabetes, and cardiovascular disease, and has surged worldwide in recent decades. The findings, published in Nature Climate Change, suggest that rising heat could be nudging more people towards high-sugar products such as soda, juice and ice cream.
Climate link to diet
Researchers from the UK and US analysed data from American households between 2004 and 2019 and compared purchases with local weather conditions. They found that for every additional degree Celsius within the range of 12–30°C, people consumed an extra 0.7 grams of sugar per day on average.
Those with lower incomes or less education were the most affected, according to the study. Under worst-case climate scenarios, disadvantaged groups could be consuming up to five additional grams of sugar daily by the end of the century, lead author Pan He of Cardiff University told AFP.
Beyond recommended limits
The American Heart Association recommends a maximum daily intake of 36 grams of added sugar for men and 24 grams for women. However, most Americans already consume two to three times these amounts. A single can of soda contains about 40 grams of sugar.
The study showed that the increase in sugar consumption levelled off once temperatures rose above 30°C. Co-author Duo Chan of the University of Southampton suggested this may be because people had already altered their diets by that point. He warned this could be “even worse news”, as it showed dietary changes were occurring even at lower, not extreme, temperatures.
Substituting frozen treats
The research also indicated a drop in purchases of baked goods on hotter days, likely because consumers were substituting them with ice cream or other frozen desserts.
Health concerns
Unhealthy diets are among the four main risk factors for diseases that account for more than 70 per cent of deaths worldwide, according to the World Health Organization. The authors concluded that climate change, by shaping dietary choices, could further worsen public health outcomes.
How noticing the changes in my father taught me the importance of early action, patience, and love
I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.
Earlier this year, I had the privilege of looking after my parents – they lived with me while their old house was being sold, and their new house was being renovated.
Within this time, I noticed things happening to my dad (Chamanlal Mulji), an 81-year-old retired joiner. Dad was known as Simba when he lived in Zanzibar, East Africa because he was like a lion. A man in fairly good health, despite being an ex-smoker, he’d only had heart surgery back in 2017. In the last few years, he was having some health issues, but certain things, like his walking and driving becoming slow, and his memory failing, we just put down to old age. Now, my dad was older than my friend’s dad. Many of whom in their 70’s, dad, at 81 was an older dad, not common back in the seventies when he married my mum.
It was only when I spent extended time around my parents that I started noticing that certain things weren’t just due to old age. Some physical symptoms were more serious, but certain things like forgetting that the front door wasn’t the bathroom door, and talking about old memories thinking that they had recently happened rang alarm bells for me and I suspected that he might have dementia.
Dementia generally happens in old age when the brain starts to shrink. Someone described it to me as a person’s brain being like a bookshelf. The books at the top of the shelf are the new memories and the books at the bottom are the new memories. The books at the top have fallen off, leaving only the old memories being remembered. People with dementia are also highly likely to suffer from strokes.
Sadly, my dad was one of the few that suffered a stroke and passed away on 28th June 2025. If you have a parent, family member or anyone you know and you suspect that they might have dementia, please talk to your GP straight away. Waiting lists within the NHS are extremely LONG so the quicker people with dementia are treated, the better. Sadly, the illness cannot be reversed but medication can help it from getting worse.
One thing I would also advise is to have patience. Those suffering with dementia can be agitated and often become aggressive, but that’s only because they’re frustrated that they cannot do things the way they used to.
The disease might hide the person underneath, but there’s still a person in there who needs your love and attention.” - Jamie Calandriello
This one is for you, dad x
Keep ReadingShow less
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro
Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
A new discount deal with UK suppliers will limit the increase for patients.
Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
NHS pricing remains unaffected due to separate arrangements.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.
Why the price rise was announced
Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.
Discount deal for UK suppliers
The revised agreement will see the top-dose price set at £247.50 for suppliers. While pharmacies and private providers will still add their own margins, the increase for patients is now likely to remain under 50% for higher doses, and even lower for smaller doses.
Eli Lilly confirmed:
“We are working with private providers on commercial arrangements to maintain affordability and expect these to be passed onto patients when the change is effective on 1 September.”
Impact on consumers
Around 1.5 million people in the UK are currently on weight-loss drugs, with more than half using Mounjaro. Most of these patients—around 90%—pay privately through online services or high street pharmacies.
Prices vary between providers, depending on the level of lifestyle and dietary support offered alongside the injections.
Olivier Picard of the National Pharmacy Association said:
“This rebate will mitigate some of the impact of the increase, but patients should still anticipate seeing a rise in prices from 1 September.”
NHS pricing unchanged
The deal does not affect the NHS, which has secured its own heavily-discounted price for patients prescribed the weekly injection.
Mounjaro works by helping patients feel fuller for longer, reducing food intake and supporting weight loss of up to 20% of body weight.
Keep ReadingShow less
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)
CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.
GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. Research estimates chickenpox in childhood leads to £24 million in lost income and productivity annually.
Minister of State for Care, Stephen Kinnock, said: “We’re giving parents the power to protect their children from chickenpox and its serious complications, while keeping them in nursery or the classroom where they belong and preventing parents from scrambling for childcare or having to miss work. This vaccine puts children’s health first and gives working families the support they deserve. As part of our Plan for Change, we want to give every child the best possible start in life, and this rollout will help to do exactly that.”
Dr Gayatri Amirthalingam, Deputy Director of Immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal. It is excellent news that from next January we will be introducing a vaccine to protect against chickenpox into the NHS routine childhood vaccination programme – helping prevent what is for most a nasty illness and for those who develop severe symptoms, it could be a life saver.”
Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “This is a hugely positive moment for families as the NHS gets ready to roll out a vaccine to protect children against chickenpox for the first time, adding to the arsenal of other routine jabs that safeguard against serious illness.”
The eligibility criteria will be set out in clinical guidance, and parents will be contacted by their GP surgery if their child is eligible.